Sudeep Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,151	267.39	368.07	139.76	103.01	214.74
Short-Term Investments	-	879.06	150	-	-	-
Trading Asset Securities	-	-	1.36	1.27	30.33	-
Cash & Short-Term Investments	1,151	1,146	519.43	141.03	133.34	214.74
Cash Growth	70.26%	120.71%	268.32%	5.77%	-37.91%	654176.23%
Accounts Receivable	2,461	2,275	1,854	1,446	937.12	1,066
Other Receivables	-	441.25	313.39	231.64	320.71	111.51
Receivables	2,463	2,720	2,170	1,690	1,268	1,185
Inventory	2,749	2,160	1,287	665.82	709.97	365.35
Prepaid Expenses	-	56.47	88.32	18.51	13.73	4.98
Other Current Assets	869.64	156.64	176.82	237.86	175.58	191.77
Total Current Assets	7,233	6,240	4,241	2,754	2,300	1,962
Property, Plant & Equipment	4,982	4,469	2,773	2,246	1,838	1,459
Long-Term Investments	-	152.68	3.33	3.2	2.05	1.94
Goodwill	674.5	682.4	-	-	-	-
Other Intangible Assets	119.37	67.53	2.1	3.02	3.95	-
Long-Term Deferred Tax Assets	11.32	4.95	3.25	2.28	5.44	4.74
Other Long-Term Assets	265.4	132.2	148.43	130.62	51.49	22.88
Total Assets	13,286	11,749	7,172	5,139	4,201	3,450

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	976.27	684.28	604.8	507.1	384.96	305.54
Accrued Expenses	-	66.58	47.85	40.71	514.57	578.16
Short-Term Debt	-	1,019	852.88	548.3	518.17	484.8
Current Portion of Long-Term Debt	1,252	121.21	104.13	97.16	104.97	70
Current Portion of Leases	8.37	7.98	6.44	7.51	2.86	2.2
Current Income Taxes Payable	54.34	9.84	27.88	1.72	20.04	9.66
Other Current Liabilities	197.37	110.93	103.59	170.11	162.72	24.83
Total Current Liabilities	2,489	2,020	1,748	1,373	1,708	1,475
Long-Term Debt	624.27	342.86	395.53	111.43	199.41	282.34
Long-Term Leases	9.06	13.37	16.55	22.99	5.42	8.28
Pension & Post-Retirement Benefits	5.82	0.39	2.9	3.94	-	2.12
Long-Term Deferred Tax Liabilities	124.38	94.03	63.59	58.47	51.33	48.48
Other Long-Term Liabilities	305.63	297.58	14.64	9.27	3.83	5.54
Total Liabilities	3,558	2,768	2,241	1,579	1,968	1,822

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	112.95	112.95	97.23	14.09	14.09	14.09
Additional Paid-In Capital	-	2,490	-	98.56	98.56	98.56
Retained Earnings	-	6,287	4,856	3,478	2,150	1,527
Comprehensive Income & Other	9,460	-56.76	-21.85	-30.74	-30.08	-11.18
Total Common Equity	9,573	8,833	4,931	3,560	2,233	1,628
Minority Interest	155.11	147.54	-	-	-	-
Shareholders' Equity	9,728	8,981	4,931	3,560	2,233	1,628
Total Liabilities & Equity	13,286	11,749	7,172	5,139	4,201	3,450

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	1,894	1,504	1,376	787.39	830.83	847.62
Net Cash (Debt)	-742.87	-357.77	-856.1	-646.37	-697.49	-632.88
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.55	-3.21	-7.89	-5.96	-6.43	-5.83
Filing Date Shares Outstanding	112.1	112.95	97.23	31	1.41	1.41
Total Common Shares Outstanding	112.1	112.95	97.23	31	1.41	1.41
Working Capital	4,744	4,220	2,494	1,381	591.89	486.41
Book Value Per Share	85.40	78.21	50.72	114.84	1584.59	1155.38
Tangible Book Value	8,779	8,083	4,929	3,557	2,229	1,628
Tangible Book Value Per Share	78.32	71.57	50.69	114.74	1581.79	1155.38
Land	-	133.17	133.17	132.89	131.5	68.48
Buildings	-	1,188	896.82	840.79	702.97	684.18
Machinery	-	1,191	875.05	783.77	652.02	467.49
Construction In Progress	-	1,784	882.17	446.61	259.72	81.27
Leasehold Improvements	-	30.76	30.76	-	-	-